For a 5mg vial reconstituted with 2ml of bacteriostatic water, the concentration drops to 2.5mg/ml
GLP-1 medications can slow gastric emptying, causing nausea, early fullness, bloating, gas, constipation, and reflux, especially during dose increases
#Pharmacy #Pharmacology #GLP1 #Semaglutide #Endocrinology #DiabetesCare #PharmaceuticalScience #MedicalAffairs #Obesity #ClinicalKnowledge It will be nice to explore the side effect profile os DPP-4 inhibitors compared to GLP-1 agonist as of todays use of GLP-1 and their higher doses to reduce body weight
GLP-1 medications restore what the body is not doing on its own
During the initial month of Wegovy treatment, a 0.25 mg injection is utilized, in the second month - a 0.5 mg dose, in the third month - a 1 mg dose, in the fourth month - a 1.7 mg dose, and from the fifth month onwards - a 2.4 mg dose